Monotherapy with piperacillin/tazobactam versus cefepime as empirical therapy for febrile neutropenia in pediatric cancer patients: a randomized comparison. - Wikidata - wikimedia - TriplyDB

Monotherapy with piperacillin/tazobactam versus cefepime as empirical therapy for febrile neutropenia in pediatric cancer patients: a randomized comparison.

Monotherapy with piperacillin/tazobactam versus cefepime as empirical therapy for febrile neutropenia in pediatric cancer patients: a randomized comparison.

http://www.wikidata.org/entity/Q40484723

about

Anti-pseudomonal beta-lactams for the initial, empirical, treatment of febrile neutropenia: comparison of beta-lactams A systematic review and meta-analysis of anti-pseudomonal penicillins and carbapenems in pediatric febrile neutropenia.The Dose-Dependent Efficacy of Cefepime in the Empiric Management of Febrile Neutropenia: A Systematic Review and Meta-Analysis.A clinical evaluation of efficacy and safety of cefepime monotherapy versus piperacillin-tazobactam in patients of paediatric age group with febrile neutropenia in a tertiary care centre of north India.A randomized trial of cefozopran versus cefepime as empirical antibiotic treatment of febrile neutropenia in pediatric cancer patients.Do proinflammatory cytokine levels predict serious complication risk of infection in pediatric cancer patients?Randomized comparison of piperacillin-tazobactam plus amikacin versus cefoperazone-sulbactam plus amikacin for management of febrile neutropenia in children with lymphoma and solid tumors.Comparison of piperacillin tazobactam and cefoperazone sulbactam monotherapy in treatment of febrile neutropenia.Piperacillin/tazobactam monotherapy versus piperacillin/tazobactam plus amikacin as initial empirical therapy for febrile neutropenia in children with acute leukemia.Piperacillin/tazobactam versus cefozopran for the empirical treatment of pediatric cancer patients with febrile neutropenia.Comparison of sulbactam-cefoperazone with carbapenems as empirical monotherapy for febrile neutropenic children with lymphoma and solid tumors.Piperacillin/tazobactam plus amikacin versus carbapenem monotherapy as empirical treatment of febrile neutropenia in childhood hematological malignancies.Febrile neutropenia in children with cancer: a retrospective Norwegian multicentre study of clinical and microbiological outcome.Comparison between piperacillin/tazobactam and cefepime monotherapies as an empirical therapy for febrile neutropenia in children with hematological and malignant disorders: A prospective, randomized study.Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 Update by the Infectious Diseases Society of America.Cefepime Efficacy and Safety in Children: A Systematic Review and Meta-analysis.A prospective randomized trial comparing piperacillin/tazobactam with meropenem as empirical antibiotic treatment of febrile neutropenic children and adolescents with hematologic and malignant disorders.Effect of Combination Therapy of Ceftazidime/Amikacin and Monotherapy with Imipenem on the Treatment of Fever and Neutropenia in Patients with Cancers

P2860

Q24236653-E415C8B0-E1B2-41FA-82AD-7E38C36F11E1 Q37964460-8379412D-330E-43F9-BBAA-441D449BD7BE Q40111888-4A4B7B8F-E2A9-48B8-A0BD-2A6305A453B6 Q40129133-A44989D6-E26A-4AA9-8827-E4597F58A912 Q40196511-85E4F2A4-87AC-43FB-9D33-291A58331284 Q40218826-DC1353DC-BAB3-474D-A042-56973009134D Q40261563-B8287C69-1713-46AB-B6C8-9E7C6FB4B3C2 Q40321694-71189A5C-AAF5-48C3-A617-35D58CA77849 Q40326885-19D5926A-D735-4BB9-BC0A-A609771D4A9D Q40329901-CAE3E520-F1C2-4852-88F2-FE0004C5113D Q40330624-35E79C5E-FB34-4053-B365-5B8F81B29A4E Q40419049-39021A9A-6B33-4563-B5A7-E620D9A988A6 Q40437471-0311160B-2380-4D4B-B413-CF8CDB9B4A4D Q41513406-0E854A61-9696-49B5-81F9-024CE116F103 Q51617424-341DC8E5-AD65-4867-96B4-601E07DE3F8E Q53275936-C398E68B-9479-4E44-9928-E1F9EF067223 Q53668374-A69F85ED-32E0-454E-AB6C-0A58E936C3DE Q58766888-B42475A4-056F-40C1-8483-3B3B7CA76CAF

P2860

Monotherapy with piperacillin/tazobactam versus cefepime as empirical therapy for febrile neutropenia in pediatric cancer patients: a randomized comparison.

http://www.wikidata.org/entity/Q40484723

description

2006 nî lūn-bûn

@nan

2006年の論文

@ja

2006年学术文章

@wuu

2006年学术文章

@zh-cn

2006年学术文章

@zh-hans

2006年学术文章

@zh-my

2006年学术文章

@zh-sg

2006年學術文章

@yue

2006年學術文章

@zh

2006年學術文章

@zh-hant

name

Monotherapy with piperacillin/ ...... ents: a randomized comparison.

@en

type

label

Monotherapy with piperacillin/ ...... ents: a randomized comparison.

@en

prefLabel

Monotherapy with piperacillin/ ...... ents: a randomized comparison.

@en

P1433

Q40484723-FBC0F23F-4055-4691-9DCA-BBEE3579B4FD

P1476

Q40484723-27DE5CCC-D595-408F-9B7C-0425C4A03C2B

P2093

Q40484723-9BD37458-B7BD-4C91-BD12-98BED9A223AF

Q40484723-BBF2EE0B-7B25-4261-9141-79A5527380D1

Q40484723-CAB2E491-9E79-4778-BDEF-2A649376B063

P2860

Q40484723-17732880-4D7A-4E22-A2AE-C0F7F7D776ED

Q40484723-239C71A9-BE11-4AE8-91CF-15911028E6E0

Q40484723-30566508-4084-413C-A01F-D0BD354BC601

Q40484723-438738A7-49C5-4B49-8A83-1C7BBEFAB238

Q40484723-4EE3C4A9-CAB3-41D7-87CB-D30F2EC7B1F6

Q40484723-4F6136D6-3C33-4F33-ACB9-88A42D9BA83F

Q40484723-5708E495-7E13-4A8D-9873-5CFD57B74FB8

Q40484723-6213FAFB-003A-40C8-9E1D-59226C57C995

Q40484723-7DD272F0-D158-4866-A67E-BC92D473CC32

Q40484723-8CE07909-FB0C-46CA-A943-D40F5B097BB6

P304

Q40484723-4509F15E-DBC6-40CD-8597-B8870DA5A6F4

P31

Q40484723-191CA009-E515-4367-9F09-B62E981B0F7B

P356

Q40484723-2DF3E4D1-BAA4-4117-9F12-5B62169902F9

P433

Q40484723-2FF41D9C-DB44-47C0-B799-849AAA6587E8

P478

Q40484723-CF3B879F-F015-4BA4-8023-9F1DDD3138D8

P577

Q40484723-913457BE-4DBA-4530-8AB7-32BA56B83FF4

P698

Q40484723-254869AE-43A6-453D-813B-368F3C1A3404

P356

08880010500506370

P1433

Pediatric Hematology and Oncology

P1476

Monotherapy with piperacillin/ ...... ents: a randomized comparison.

@en

P2093

Emine Zengin

http://www.w3.org/2001/XMLSchema#string

Funda Corapcioglu

http://www.w3.org/2001/XMLSchema#string

Nazan Sarper

http://www.w3.org/2001/XMLSchema#string

P2860

Is monotherapy for febrile neutropenia still a viable alternative?

2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer.

Comparative study of cefepime versus ceftazidime in the empiric treatment of pediatric cancer patients with fever and neutropenia.

Piperacillin-tazobactam plus amikacin versus ceftazidime plus amikacin as empiric therapy for fever in granulocytopenic patients with cancer. The International Antimicrobial Therapy Cooperative Group of the European Organization for Research and Tre

Single-dose pharmacokinetics of piperacillin and tazobactam in infants and children.

Cefepime versus ceftazidime + amikacin as empirical therapy for febrile neutropenia in children with cancer: a prospective randomized trial of the treatment efficacy and cost.

Meropenem plus amikacin versus piperacillin-tazobactam plus netilmicin as empiric therapy for high-risk febrile neutropenia in children.

Piperacillin-tazobactam and netilmicin as a safe and efficacious empirical treatment of febrile neutropenic children.

Cefepime vs. Meropenem as empirical therapy for neutropenic fever in children with lymphoma and solid tumours.

Vancomycin versus placebo for treating persistent fever in patients with neutropenic cancer receiving piperacillin-tazobactam monotherapy.

P304

177-186

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/08880010500506370

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

23

http://www.w3.org/2001/XMLSchema#string

P577

2006-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

16517534

http://www.w3.org/2001/XMLSchema#string